SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-23-169657
Filing Date
2023-06-20
Accepted
2023-06-20 08:20:26
Documents
5
Group Members
DURNING ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-C d511803dsctoc.htm SC TO-C 20301
2 EX-99.1 d511803dex991.htm EX-99.1 18339
3 GRAPHIC g511803dsp04.jpg GRAPHIC 2770
4 GRAPHIC g511803dsp04a.jpg GRAPHIC 3918
5 GRAPHIC g511803dsp04c.jpg GRAPHIC 4350
  Complete submission text file 0001193125-23-169657.txt   56245
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC TO-C | Act: 34 | File No.: 005-92879 | Film No.: 231023475
SIC: 2834 Pharmaceutical Preparations